Tianshu Liu Selected Research

Tianshu Liu Research Topics

Disease

83	Neoplasms (Cancer) 05/2024 - 08/2012
62	Stomach Neoplasms (Stomach Cancer) 03/2024 - 01/2013
35	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 09/2013
22	Neoplasm Metastasis (Metastasis) 03/2024 - 03/2013
21	Adenocarcinoma 12/2023 - 01/2013
14	Disease Progression 01/2024 - 01/2013
9	Myocarditis (Carditis) 01/2024 - 01/2020
8	Inflammation (Inflammations) 03/2024 - 01/2018
8	Hypertension (High Blood Pressure) 02/2024 - 06/2015
5	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024 - 07/2016
5	Proteinuria 02/2024 - 01/2017
5	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2017
5	Hepatocellular Carcinoma (Hepatoma) 08/2019 - 03/2013
4	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2024 - 09/2021
4	Sarcoma (Soft Tissue Sarcoma) 12/2023 - 02/2019
4	Carcinogenesis 01/2023 - 06/2014
4	Esophageal Squamous Cell Carcinoma 01/2022 - 06/2017
3	Lung Neoplasms (Lung Cancer) 09/2023 - 02/2014
3	Osteoporosis 02/2023 - 01/2017
3	Anemia 10/2022 - 01/2020
3	Diarrhea 01/2022 - 09/2013
2	Ischemic Stroke 03/2024 - 05/2021
2	Neutropenia 04/2023 - 08/2012
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2023 - 01/2022
2	Exanthema (Rash) 10/2022 - 06/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 01/2013
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

23	Biomarkers (Surrogate Marker)IBA 03/2024 - 06/2014
17	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2020
17	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2024 - 12/2014
12	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2013
10	Fluorouracil (Carac)FDA LinkGeneric 01/2024 - 12/2014
10	Trastuzumab (Herceptin)FDA Link 11/2023 - 02/2016
9	human ERBB2 proteinIBA 12/2023 - 02/2016
9	Cetuximab (Erbitux)FDA Link 06/2023 - 12/2016
9	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2017
8	NivolumabIBA 12/2023 - 01/2021
8	Capecitabine (Xeloda)FDA Link 01/2022 - 12/2014
6	Monoclonal AntibodiesIBA 01/2024 - 12/2016
6	ErbB Receptors (EGF Receptor)IBA 03/2023 - 12/2016
5	Gemcitabine FDA Link 04/2024 - 08/2012
5	Irinotecan (Camptosar)FDA LinkGeneric 01/2024 - 09/2013
5	Leucovorin (Folinic Acid)FDA Link 05/2023 - 12/2014
5	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2022 - 06/2015
5	HMPL-013IBA 01/2022 - 01/2017
5	Cell-Free Nucleic AcidsIBA 09/2021 - 01/2017
5	bazedoxifeneIBA 02/2021 - 03/2019
5	XELOXIBA 01/2020 - 12/2014
4	camrelizumabIBA 05/2024 - 01/2020
4	Therapeutic UsesIBA 03/2024 - 01/2021
4	PlatinumIBA 06/2023 - 09/2015
4	Docetaxel (Taxotere)FDA Link 04/2023 - 01/2013
4	asparaginylendopeptidase (legumain)IBA 03/2023 - 06/2016
4	Bevacizumab (Avastin)FDA Link 03/2023 - 01/2013
4	Transcription Factors (Transcription Factor)IBA 01/2023 - 06/2016
4	ParaffinIBA 01/2022 - 01/2015
4	apatinibIBA 01/2022 - 01/2017
4	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2020 - 05/2017
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2024 - 08/2019
3	LigandsIBA 04/2024 - 01/2021
3	Apolipoproteins E (ApoE)IBA 03/2024 - 11/2020
3	Alanine Transaminase (SGPT)IBA 02/2024 - 06/2015
3	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 10/2020
3	RNA (Ribonucleic Acid)IBA 06/2023 - 01/2020
3	EnzymesIBA 03/2023 - 01/2018
3	AntioxidantsIBA 02/2023 - 03/2019
3	surufatinibIBA 01/2023 - 11/2020
3	Ursolic AcidIBA 01/2023 - 08/2017
3	tislelizumabIBA 09/2022 - 01/2020
3	IpilimumabIBA 01/2022 - 01/2022
3	Circulating Tumor DNAIBA 01/2022 - 09/2019
3	Formaldehyde (Formol)FDA Link 01/2022 - 01/2015
3	regorafenibIBA 01/2022 - 06/2015
3	B7-H1 AntigenIBA 01/2022 - 01/2022
3	CytokinesIBA 09/2021 - 05/2017
3	ApolipoproteinsIBA 02/2021 - 01/2018
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2016
3	Raloxifene Hydrochloride (Evista)FDA Link 11/2020 - 01/2017
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2020 - 01/2019
2	famitinibIBA 05/2024 - 02/2024
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024 - 01/2021
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2024 - 01/2022
2	Phosphotransferases (Kinase)IBA 12/2023 - 01/2022
2	pyrotinibIBA 11/2023 - 01/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2023 - 10/2020
2	Fatty Acids (Saturated Fatty Acids)IBA 03/2023 - 10/2020
2	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2023 - 01/2022
2	Indicators and Reagents (Reagents)IBA 01/2023 - 02/2021
2	130-nm albumin-bound paclitaxelIBA 01/2023 - 01/2022
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 11/2021
2	Angiotensin IIIBA 01/2022 - 01/2018

Therapy/Procedure

55	Drug Therapy (Chemotherapy) 03/2024 - 08/2012
47	Therapeutics 04/2024 - 02/2014
8	Neoadjuvant Therapy 12/2023 - 01/2014
6	Immunotherapy 03/2024 - 01/2020
5	Gastrectomy 01/2022 - 01/2019
3	Aftercare (After-Treatment) 01/2022 - 09/2013
2	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 01/2022
2	Lasers (Laser) 01/2022 - 09/2021